Utility of csf in differentiating cns inflammatory demyelinating disease from cns lymphoma

被引：0
|
作者：
Ikeguchi, R. [1 ]
Shimizu, Y. [1 ]
Shimizu, S. [2 ]
Kitagawa, K. [1 ]
机构：
[1] Tokyo Womens Med Univ, Sch Med, Dept Neurol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Sch Med, Med Res Inst, Tokyo, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.498
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
472
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [31] Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
    Dale, Russell C.
    Brilot, Fabienne
    Duffy, Lisa V.
    Twilt, Marinka
    Waldman, Amy T.
    Narula, Sona
    Muscal, Eyal
    Deiva, Kumaran
    Andersen, Erik
    Eyre, Michael R.
    Eleftheriou, Despina
    Brogan, Paul A.
    Kneen, Rachel
    Alper, Gulay
    Anlar, Banu
    Wassmer, Evangeline
    Heineman, Kirsten
    Hemingway, Cheryl
    Riney, Catherine J.
    Kornberg, Andrew
    Tardieu, Marc
    Stocco, Amber
    Banwell, Brenda
    Gorman, Mark P.
    Benseler, Susanne M.
    Lim, Ming
    NEUROLOGY, 2014, 83 (02) : 142 - 150
  • [32] Clinical use of CSF neopterin levels in CNS demyelinating diseases
    Miyaue, Noriyuki
    Hosokawa, Yuko
    Yamanishi, Yuki
    Tada, Satoshi
    Ando, Rina
    Nagai, Masahiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 441
  • [33] Clinical-Radiological-Pathological Spectrum of CNS Inflammatory Demyelinating Disease in the Elderly
    Costanzi, Chiara
    Bunyan, Reem
    Guo, Yong
    Parisi, Joseph
    Linbo, Linda
    Lucchinetti, Claudia
    NEUROLOGY, 2012, 78
  • [34] The clinical and radiographic spectrum of biopsy-proven CNS inflammatory demyelinating disease
    Lucchinetti, C.
    Metz, I.
    Weigand, S.
    Thomsen, K.
    Mandrekar, J.
    Erickson, B.
    Brueck, W.
    Altintas, A.
    Koenig, F. B.
    Parisi, J.
    Scheithauer, B.
    Giannini, C.
    Linbo, L.
    Lassmann, H.
    Gavrilova, R.
    MULTIPLE SCLEROSIS, 2007, 13 : S75 - S75
  • [35] Abnormal T cell reactivities in childhood inflammatory demyelinating disease and CNS injury
    Banwell, Brenda
    Cheung, Roy
    Kennedy, Julia
    Krupp, Lauren
    Becker, Dorothy
    Dosch, Hans-Michael
    Bar-Or, Amit
    NEUROLOGY, 2008, 70 (11) : A410 - A410
  • [36] CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease
    Rosenthal, Jacqueline F.
    Hoffman, Benjamin M.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 321 - 330
  • [37] The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions
    Hardy, Todd A.
    Guo, Yong
    Flanagan, Eoin P.
    Lucchinetti, Claudia F.
    Tobin, W. Oliver
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (11) : 1710 - 1718
  • [38] Disease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNS
    Park, Soo Jin
    Jeong, In Hye
    Kong, Byung Soo
    Lee, Jung-Eun
    Kim, Kyoung Heon
    Lee, Do Yup
    Kim, Ho Jin
    PLOS ONE, 2016, 11 (11):
  • [39] B cells and antibodies in CNS demyelinating disease
    Cross, AH
    Trotter, JL
    Lyons, JA
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) : 1 - 14
  • [40] Cystatin F induction in demyelinating disease of CNS
    Ma J. M.
    Tanaka, K.
    Yanada, G.
    Ikenaka, K.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 110 - 111
12345